Biophytis SA
Change company Symbol lookup
Select an option...
BPTS Biophytis SA
APA APA Corp (US)
CHI Calamos Convertible Opportunities and Income Fund
AAPL Apple Inc
ESI Element Solutions Inc
STXB Spirit of Texas Bancshares Inc
ED Consolidated Edison Inc
SNAP Snap Inc
THQ Tekla Healthcare Opportunities Fund
TGIOY Tung Ho Steel Enterprise Corp
Go

Health Care : Biotechnology | Small Cap Value
Based in France
Company profile

Biophytis SA, formerly Institut Biophytis Sas is a France-based company engaged in the healthcare industry. The Company is a biotechnology entity specialized in the development of drug candidates to treat ageing diseases. Its two programs relate to sarcopenia (loss of muscle functionality) and Age Related Macular Degeneration (ARMD). Biophytis SA is engaged in the clinical and regulatory development of its drug candidates, such as Sarconeos (BIO101) and Macuneos (BIO201), simultaneously in the United States and domestic market.

This security is an American depositary receipt
ADR Fees
American Depositary Receipt (ADR) Fee

ADR fees charged by custodial banks normally average from 1 to 3 cents per share. Other country fees might apply. To read more, see the Exception Fees tab at Brokerage Fees

Closing Price
$6.08
Day's Change
0.0827 (1.38%)
Bid
--
Ask
--
B/A Size
--
Day's High
6.08
Day's Low
6.08
Volume
(Heavy Day)
Volume:
267

10-day average volume:
2,702
267
  • Prev Close
    6.00
  • Today's Open
    6.08
  • Day's Range
    6.08-6.08
  • Avg Vol (10-day)
    2.7K
  • Last (time)
    9:31a ET 10/28/21
  • Last (size)
    7
  • 52-Wk Range
    6.00 - 18.50
    LowHigh
  • (02/10/21 - 10/27/21)
    1.38%
  • 82.4%
  • Market Cap
    76.5M
  • Shares Outstanding
    12.6M
  • --
  • --x
  • No dividend
  • Ex-dividend Date
    No dividend
  • Dividend Pay Date
    No dividend
  • --
  • --
  • --

Earnings Calendar and Events Data provided by |Terms of Use| © 2021 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2021. All rights reserved.